KrishnaV.KomanduriMD
Hematology • San Francisco, CAHematologic Oncology
Julius R. Krevans, MD Distinguished Professor of Medicine; Chief, UCSF Health Division of Hematology/Oncology; Physician-in-Chief, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco
Dr. Komanduri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
400 Parnassus Ave
Ste 3039
San Francisco, CA 94143Phone+1 415-476-1000Fax+1 305-243-6361- Is this information wrong?
Summary
- Dr. Krishna Komanduri is an academic hematologist and medical oncologist who specializes in hematopoietic transplantation and cellular therapy. He received his medical degree from University of Minnesota Medical School and has been in practice 26 years. He has laboratory expertise in translational immunology, and has expertise in health care delivery, value and access to therapies.
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1994 - 1997
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1991 - 1994
University of Minnesota Medical SchoolClass of 1991
Certifications & Licensure
FL State Medical License 2008 - 2025
CA State Medical License 2023 - 2025
TX State Medical License 2003 - 2012- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- President American Society for Transplantation and Cellular Therapy, 2017-2018
- Chair, Advisory Group on Financial Barriers to Transplantation National Marrow Donor Program
- Co-Chair, Working Committee, Infections and Immune Reconstitution Center for International Blood & Marrow Transplant Research
- Join now to see all
Clinical Trials
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
- Immune Reconstitution in Stem Cell Transplant Recipients Start of enrollment: 2012 Aug 15
Publications & Presentations
PubMed
- Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy.Allison Betof Warner, Omid Hamid, Krishna Komanduri, Rodabe Amaria, Marcus O Butler, John Haanen, Sarah Nikiforow, Igor Puzanov, Amod Sarnaik, Michael R Bishop, Adam J...> ;Journal for Immunotherapy of Cancer. 2024 Feb 29
- 30 citationsImmune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome.Ombrello, A. K., Ombrello, A. K., Melissa R Hines, Tristan E Knight, Kevin O McNerney, Mark B Leick, Tania Jain, Sairah Ahmed, Matthew J Frigault, Joshua A Hill, Micha...> ;Transplantation and Cellular Therapy. 2023 Jul 1
- 14 citationsCell-Autonomous Cxcl1 Sustains Tolerogenic Circuitries and Stromal Inflammation via Neutrophil-Derived TNF in Pancreatic Cancer.Anna Bianchi, Iago De Castro Silva, Nilesh U Deshpande, Samara Singh, Siddharth Mehra, Vanessa T Garrido, Xinyu Guo, Luis A Nivelo, Despina S Kolonias, Shannon J Saigh...> ;Cancer Discovery. 2023 Jun 2
- Join now to see all
Abstracts/Posters
- Multiple Pathways Targeting CD25 or TNFRSF25 Affect CD4+FoxP3+ Regulatory T Cell Phenotype and Suppressive FunctionKrishna V Komanduri, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Post-Marketing Use Outcomes of an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, Axicabtagene Ciloleucel (Axi-Cel), for the Treatment of Large B Cell Lympho...Krishna V Komanduri, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- The Innate Immune Sensor Sting Promotes Donor CD8+ T Cell Activation and Recipient APC Death Early after Preclinical Allogeneic Hematopoietic Stem Cell TransplantationKrishna V Komanduri, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
Renowned Hematology-Oncology Specialist to Lead UCSF Health’s Hematology-Oncology ProgramMarch 24th, 2022
Biomarker-Driven Cancer Care Is Not Reaching All AmericansSeptember 5th, 2020
Using Your Immune System to Fight Cancer Is Showing Significant PromiseMay 26th, 2017- Join now to see all
Grant Support
- Immune Reconstitution After Cord Blood TransplantationNational Heart, Lung, And Blood Institute2009–2011
- T Cell Reconstitution After Allogeneic SCTNational Cancer Institute2009
- Immune Reconstitution After Cord Blood TransplantationNational Heart, Lung, And Blood Institute2008
- T Cell Reconstitution After Allogeneic SCTNational Cancer Institute2005–2008
Committees
- Founding Member, ASBMT Education Committee 2010 - 2015
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
